$21.17+1.29%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Immunome last closed at $21.17 (+1.29%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -9.4×. Its overall grade ranks 326 of 741 stocks in Healthcare.
About this company
Immunome last closed at $21.17 (+1.29%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 326/741
Valuation grade A
Related stocks
- AbbVieCompetitor
항체·항암 치료제 포트폴리오를 가진 대형 바이오 제약사
- AmgenCompetitor
항체 기반 항암·면역 치료제 개발 경쟁사
- GenmabCompetitor
항체/면역항암제 개발에서 경쟁하는 바이오테크
ETFs holding this stock
WisdomTree BioRevolution Fund
Details →About Immunome
- What technical signals does Immunome (IMNM) have?
- Immunome current technical signals: no active technical signal.
- Is Immunome a cup-and-handle pattern?
- No. Immunome has no valid Cup signal right now.
- What published figures are available for Immunome?
- Market cap: $2.34B. Trailing 12 months PER: -9.4×. Latest quarter PBR: 4.57×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Immunome, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy